TCT 66: Effect of DAPAgliflozin on Myocardial Fibrosis and Ventricular Function in Patients with ST-Segment Elevation Myocardial Infarction: the DAPA-STEMI Trial

Presenter: Claudio Laudani

REGISTER for free or LOG IN to view this content

We Recommend